Molecular diagnosis of an infant with TSC2/PKD1 contiguous gene syndrome

Keita Osumi1, Kenichi Suga1, Akemi Ono1

  • 1Department of Pediatrics, Tokushima University Hospital, Kuramotocho, Tokushima, Tokushima Japan.

Insights

A rare contiguous gene syndrome involving TSC2 and PKD1 was identified in an infant with cardiac rhabdomyoma. Early molecular diagnosis of this deletion syndrome aids in detecting kidney issues and managing this complex condition.

Area of Science:

  • Genetics
  • Pediatrics
  • Molecular Biology

Background:

  • Cardiac rhabdomyoma can be a manifestation of Tuberous Sclerosis Complex (TSC).
  • Polycystic Kidney Disease 1 (PKD1) gene mutations are associated with autosomal dominant polycystic kidney disease.
  • Contiguous gene deletions involving TSC2 and PKD1 are rare genetic disorders.

Purpose of the Study:

  • To report a case of TSC2/PKD1 contiguous gene syndrome diagnosed in an infant.
  • To highlight the utility of molecular diagnostics in identifying complex genetic deletions.
  • To emphasize the importance of early detection and multidisciplinary management for this multisystem disease.

Main Methods:

  • Targeted panel sequencing was employed for genetic analysis.
  • Quantitative polymerase chain reaction (qPCR) was used to confirm gross monoallelic deletion.
  • Clinical data from a 1-month-old Japanese infant with cardiac rhabdomyoma was reviewed.

Main Results:

  • A diagnosis of TSC2/PKD1 contiguous gene syndrome was established.
  • A gross monoallelic deletion encompassing exons 19-42 of TSC2 and exons 2-46 of PKD1 was identified.
  • The patient presented with cardiac rhabdomyoma, indicating potential for other systemic manifestations.

Conclusions:

  • Early molecular diagnosis of TSC2/PKD1 contiguous gene syndrome is crucial.
  • This diagnosis facilitates the early detection of bilateral renal cyst formation.
  • Multidisciplinary follow-up is essential for managing the multisystemic aspects of this disease.